wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55258220-4CDB755D-0B61-4AD6-B647-8874BFF7FC11
Q55258220-4CDB755D-0B61-4AD6-B647-8874BFF7FC11
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55258220-4CDB755D-0B61-4AD6-B647-8874BFF7FC11
Emerging resistance pathways in lung cancer: what has ROS-1 taught us?
P2860
Q55258220-4CDB755D-0B61-4AD6-B647-8874BFF7FC11
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55258220-4CDB755D-0B61-4AD6-B647-8874BFF7FC11
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10830b062e5011e55c0922adab6ea662e18c8824
P2860
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.